Molecular Cancer | Articles which cite: Effects of STI571 (gleevec) on pancreatic cancer cell growth.

Effects of STI571 (gleevec) on pancreatic cancer cell growth.
Li J, Kleeff J, Guo J, Fischer L, Giese N, Büchler MW, Friess H
Mol Cancer 2003 Sep 17, 2:32
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer. Kayed H, Jiang X, Keleg S, Jesnowski R, Giese T, Berger MR, Esposito I, Löhr M, Friess H, Kleeff J Br J Cancer 2007 Oct 22, 97:1106-15 [PubMed Central] [PubMed] [Related articles]
2.	Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines. Uziel O, Fenig E, Nordenberg J, Beery E, Reshef H, Sandbank J, Birenbaum M, Bakhanashvili M, Yerushalmi R, Luria D, Lahav M Br J Cancer 2005 May 23, 92:1881-91 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central

printer friendly

to [Help]